The 7 analysts offering 12-month price forecasts for Dyne Therapeutics Inc have a median target of 23.00, with a high estimate of 47.00 and a low estimate of 16.00. The median estimate represents a +55.30% increase from the last price of 14.81.
The current consensus among 7 polled investment analysts is to Buy stock in Dyne Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.87
Reporting Date Mar 02
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.